Terence Porter

Over 30 years of experience in pharmaceutical/biotechnology industry global business development and R&D. As Vice President of Search & Evaluation in the Global Business Development and Center for External Innovation groups at Takeda Pharmaceuticals, oversaw identification, evaluation and due diligence of multiple licensing and M&A opportunities in CV-Metabolic, GI, Immunology, Respiratory and CNS. As Vice President of External Science and Technology at GSK, co-led negotiations in GSK’s $450 million acquisition of Domantis. Previously headed GSK Oncology Licensing worldwide. Core member of Takeda’s Business Development & Licensing Committee and GSK’s most senior R&D scientific review and governance committee for technology platforms and compounds up to clinical proof-of-concept. BSc (Hons) in Biochemistry and Ph.D. in Chemistry from the University of Manchester, UK.